-
Part of our news team included a cameraman who was a former military sniper, a radio host who was there for the first Gulf War, a translator who was also an oncologist with a medical pass, and a driver who was also a former driver for the UN weapons inspection team (who also loved Elvis).
FORBES: Remembering the Road to Baghdad
-
Armstrong is a medical oncologist at the Johns Hopkins Kimmel Cancer Center in Baltimore.
NPR: Breast-Cancer Drop Attributed to Less Hormone Therapy
-
Brentjens, a medical oncologist at Memorial Sloan-Kettering Cancer Center, New York, and lead author of the study.
WSJ: Gene Therapy Shows Promise as Cancer Treatment
-
Prior to definitive surgery, you should meet with a medical oncologist, radiation oncologist, geneticist (if you are at risk for the breast cancer gene), and reconstructive surgeon.
FORBES: Cancer Made Me Nice: An Interview With Survivor Karen Vaniver, MD
-
Dr Michael Seckl, a medical oncologist, and his team at the hospital found that treating cancerous cells with Taxol and stem cell infusion - an advanced form of bone marrow transplantation - was successful.
BBC: 'Women's cancer drug' offers men hope
-
Philip Kantoff, a urological oncologist at Harvard Medical School and the Dana Farber Cancer Institute, is conducting a big clinical trial that should firmly establish whether and how much Provenge helps patients.
FORBES: Magazine Article
-
"Radiation is now as good as surgery, and that wasn't the case 15 years ago, " says Daniel Shasha, a radiation oncologist at Beth Israel Medical Center in New York.
FORBES: On The Cover/Top Stories
-
"I think that Avastin's a good drug, and I think we just need to figure out whom to give it to, " says Melody A. Cobleigh , an oncologist at Rush Medical College in Chicago who worked on the trial.
FORBES: Why Cancer Drugs Need Genetic Testing
-
"They say, 'Well, we'll tell her it's just a cold, or it's just a virus, or we'll tell her she'll have surgery and then everything will be fine, '" said Dr. Lawrence Wolfe, a pediatric hematologist-oncologist at Long Island Jewish Medical Center in New York.
CNN: 'Honey, you're really sick'
-
But the approval may not be a sure thing, according to Daniel Petrylak, an oncologist at Columbia University Medical Center, because Dendreon's studies did not meet their main pre-specified goal: a slowing of tumor progression.
FORBES: Magazine Article